July 3, 2025 - Health Technology Insights

July 3, 2025
HealthTech Media Room
Business, HealthTech News, News, news

INOVIO Announces Pricing of $25 Million Public Offering

INOVIO Pharmaceuticals, a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, announced the pricing of an underwritten...

July 3, 2025
HealthTech Media Room
Health, HealthTech News, Medical Research Software, news, News

Rhode Island Creates Rare Disease Advisory Council

Governor Dan McKee Signs Legislation The Rare Access Action Project (RAAP) applauds Governor Dan McKee for signing into law House Bill No. 5023 Sub A and Senate Bill No. 474 as...

July 3, 2025
HealthTech Media Room
Healthcare Staffing, HealthTech News, News, news

Lustgarten Foundation Appoints Arthur Kuan, MS, to Board of Directors

Arthur Kuan, MS, joins the Lustgarten Foundation Board of Directors The Lustgarten Foundation, the world’s largest private funder of pancreatic cancer research, announced the appointment of Arthur Kuan, MS, to...

July 3, 2025
HealthTech Media Room
HealthTech News, News, news, Pharmaceuticals

ACA Pharma Secures Fast-track Approval For Eagle Pharmaceuticals’ Ryanodex In Macau

ACA Pharma, an end-to-end commercialization partner for China & Southeast Asia, helps Eagle Pharmaceuticals secure regulatory approval in Macau for RYANODEX in under 90 days. ACA Pharma proudly announces the rapid regulatory approval of Ryanodex...

July 3, 2025
HealthTech Media Room
Biotechnology, Cancer, Genomics and Precision Medicine, HealthTech News, news, News

Johnson & Johnson Seeks EMA Approval to Extend AKEEGA Use for Prostate Cancer

The submission is based on results from the Phase 3 AMPLITUDE study evaluating niraparib in combination with abiraterone acetate plus prednisone or prednisolone compared to a current standard of...

July 3, 2025
HealthTech Media Room
AI in Healthcare, HealthTech News, News, news

AAMI Aligns With National Academy of Medicine AI Code of Conduct

AI Code of Conduct’s six core principles key to ensuring the safe and effective use of AI technologies The Association for the Advancement of Medical Instrumentation (AAMI) announces its alignment with...

July 3, 2025
HealthTech Media Room
Biotechnology, HealthTech News, News, news, Pharmaceuticals, Pharmacogenomics

Transition of Promotional Activities for Allergen Immunotherapy Drug Actair in Japan

Stallergenes Greer, Shionogi & Co., Ltd. and CEOLIA Pharma Co. Ltd announced the transition of promotional activities for Actair in Japan. Actair is Stallergenes Greer’s sublingual immunotherapy tablet for...

July 3, 2025
HealthTech Media Room
AI in Healthcare, HealthTech News, News, news, Patient Experience

Wilma Empowers ABA Practices with New Patient Management Tools

AI-Powered Software Empowers ABA Practices to Strengthen Patient Relationships and Streamline Workflows with Next-Generation Tools As the nation lights up the sky in celebration of independence, Wilma, a leading...

July 3, 2025
HealthTech Media Room
Business, HealthTech News, news, News

Verdantas Acquires Independent Solutions to Expand in Western U.S.

Verdantas, a leader in digitally enabled technical consulting solutions for the environment, water, and energy transition markets and a portfolio company of Sterling Investment Partners, has acquired Independent Solutions,...

July 3, 2025
HealthTech Media Room
Biotechnology, HealthTech News, News, news

Asahi Kasei Pharma Begins Phase III Trial of ART-123 for CIPN

Asahi Kasei Pharma has started trial drug administration in a Phase III study of ART-123 in Japan for the prevention of chemotherapy-induced peripheral neuropathy related symptoms. This announcement follows...

INOVIO Announces Pricing of $25 Million Public Offering

Rhode Island Creates Rare Disease Advisory Council

Lustgarten Foundation Appoints Arthur Kuan, MS, to Board of Directors

ACA Pharma Secures Fast-track Approval For Eagle Pharmaceuticals’ Ryanodex In Macau

Johnson & Johnson Seeks EMA Approval to Extend AKEEGA Use for Prostate Cancer

AAMI Aligns With National Academy of Medicine AI Code of Conduct

Transition of Promotional Activities for Allergen Immunotherapy Drug Actair in Japan

Wilma Empowers ABA Practices with New Patient Management Tools

Verdantas Acquires Independent Solutions to Expand in Western U.S.

Asahi Kasei Pharma Begins Phase III Trial of ART-123 for CIPN

Quick Links

Insights

Get in touch

Follow Us

Our Other Brands